Clinical Trials in Massachusetts

Showing 6481-6500 of 17,868 trials

A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder

NCT02985749

This study is an 8-week pilot trial with oxytocin nasal spray (Syntocinon) as a treatment for social impairment in children and adults with high functioning autism spectrum disorders (ASD). The investigators hypothesize that oxytocin will be safe, tolerable, and effective in improving social deficits in individuals with ASD.

Autism Spectrum DisorderPervasive Developmental DisorderASD+1 more

Massachusetts General Hospital7 participantsStarted Oct 2017

Cambridge, Massachusetts, United States

Active Not RecruitingPhase 326 miles

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

NCT04702373

This is a Phase III randomized controlled trial of a passive ROM exercise program that will be performed in infants with HLHS and other single right ventricle anomalies following the Norwood procedure at PHN and Auxiliary Centers.

Congenital Heart Disease

Carelon Research144 participantsStarted Feb 2021

Atlanta, Georgia, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +7 more locations

A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Find Trials by Condition in Massachusetts

Overcoming Barriers to Accessing Genetic Medicine

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine

Vestibular Implants Tested in Human Subjects

Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of Patients Undergoing HSCT

Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)